Based on the cBioPortal platform, we found that ELF5 expression was accompanied by gene alterations in multiple cancers such as uterine endometrioid carcinoma, breast cancer and colorectal cancer, but showed no alterations in renal cell carcinoma (Fig. S1A-B). The gene discussed is ELF5; the disease is breast cancer.